Senzo

Recent Finacing

Equity

Recent Raise

$1.8M

Senzo develops amplified lateral flow in vitro diagnostics for mobile, point-of-care, and at-home testing that deliver PCR-comparable accuracy in 10 minutes across respiratory, STI, TB, hepatitis, and environmental/veterinary applications.